Search
for
Sort by
Research 121–150 of 1000+
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Herpes zoster ophthalmicus following platelet-rich plasma therapy for androgenetic alopecia
- British Hair and Nail Society
- Cutaneous lupus erythematosus
- Topical use of systemic drugs in dermatology: A comprehensive review
- Long COVID syndrome: An unfolding enigma
- Wolf’s Isotopic Response in a Post Herpes Zoster Patient Forming Superficial Basal Cell Carcinoma
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- [Systematic treatment with sex hormones in dermatology].
- Primary cicatricial alopecia
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Patient factors influencing dermal filler complications: prevention, assessment, and treatment
- Immunosuppressive treatment for proliferative lupus nephritis
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Cutaneous Side Effects of Oral Contraceptives
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- New developments in the molecular treatment of ichthyosis: review of the literature
- Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- Improving Posttraumatic Facial Scars
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Unmasking Melasma: Confronting the Treatment Challenges
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement